Please login to the form below

Not currently logged in
Email:
Password:

Cello Health acquires US consultancy ISS

Follows recent expansion into Germany

Cello Health

Cello Health has announced further expansion into the US market with the acquisition of New Jersey-based company Innovative Science Solutions, LLC (ISS) on 15 August.

ISS is a scientific consulting firm founded by Steven Weisman, PhD and David Schwartz, PhD nearly 20 years ago. The company specialises in strategic regulatory support for the healthcare industry and scientific support on health-related issues for legal counsel.

The technical service offering includes consultancy at all stages in the regulatory process, support of FDA advisory committee meetings, and data provision in legal defence of patent and intellectual property issues. Its clients are predominantly US based, though the company also supports ex-US based clients with relevant needs in the US market.

Cello H

Stephen Highley, chairman of Cello Health and Julia Ralston, CEO, Cello Health US.

Stephen Highley, chairman of Cello Health, commented: "We are very pleased to welcome ISS to Cello Health. Consistent with Cello Health, ISS has achieved a strong reputation for provision of its scientific consulting services, and the specificity of these technical services is a perfect addition to Cello’s focus on supporting clients along the most critical drug development and successful commercialisation pathways”.

“The acquisition of ISS is an excellent strategic fit as we continue our expansion in the US,” added Julia Ralston, CEO, Cello Health US. “We are excited about how the clear synergies between this new offer and our existing capabilities will benefit Cello Health’s clients and our work tackling their biggest challenges in navigating scientific, commercial, and regulatory approaches that increase an asset’s market potential”.

The US acquisition reflects ongoing expansion at the London-headquartered firm. Last month it launched Cello Health GmbH, its new Berlin office. The company unveiled two regional directors to lead the business insights and analytics division in Germany: Heike Tombrink - regional director, Head of Cello Health Insight Germany, and Matthias Heurich – regional director, supporting Digital Innovation.

20th August 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics